Gazyvaro
Find out more about Gazyvaro in:
First-line follicular lymphoma (1L FL)
Expert discussions
Listen to insights on the most up-to-date haematology data, as discussed by experts in the field.
Congress highlights
Learn more about the key data highlights presented at congresses and how they could impact UK clinical practice.
For full details, please refer to the Gazyvaro® Summary of Product Characteristics.
1L, first-line; CLL, chronic lymphocytic leukaemia; FL, follicular lymphoma; R/R, relapsed/refractory.
M-GB-00000089
Date of preparation: June 2020